Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 10%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Octagon TherapeuticsVenture round $11M · 2 yr ago • Founded 2016 • 11-50 employees
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…
VectoryTxFounded 2020 • 51-200 employees
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Draupnir Bio is developing new innovative therapies for patients.
Vanqua BioVenture round $45M · 2 yr ago • Founded 2019 • 201-500 employees
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Better medicine, fast.. Partner with us.
Coultreon Biopharma51-200 employees
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune…

Overview

A Boston-based biotech startup developing medicines for patients with autoinflammatory disease.

News

News Harvard Gazette 4 months ago
Finalists recognized in University's flagship venture competition
Eco-friendly, AI, medical, and other inventions earn funds for President's Innovation Challenge winners.
Read more
Report
Award MLSC 2 years ago
Healey-Driscoll Administration and Massachusetts Life Sciences Center Announce Awardees for Public-Private Initiative to Support Diverse Entrepreneurs
Awardees represent first cohort of recently expanded MassNextGen Initiative Cambridge, MA-Today, Secretary of Economic Development Yvonne Hao joined the
Read more
Report